GENEMEDICINE Trademark
Trademark Overview
On Thursday, July 19, 2001, a trademark application was filed for GENEMEDICINE with the United States Patent and Trademark Office. The USPTO has given the GENEMEDICINE trademark a serial number of 78074720. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, May 23, 2002. This trademark is owned by Valentis, Inc.. The GENEMEDICINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
scientific research and development of drugs to treat disease
General Information
| Serial Number | 78074720 |
| Word Mark | GENEMEDICINE |
| Filing Date | Thursday, July 19, 2001 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, May 23, 2002 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | scientific research and development of drugs to treat disease |
| Pseudo Mark | GENE MEDICINE |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 24, 2001 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Valentis, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Burlingame, CA 94010 |
Trademark Events
| Event Date | Event Description |
| Thursday, May 23, 2002 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, September 18, 2001 | NON-FINAL ACTION MAILED |
| Monday, September 10, 2001 | ASSIGNED TO EXAMINER |
